|
|
Volumn 26, Issue 13, 2008, Pages 2231-2232
|
|
Hepatic arterial infusion: The beginning of the combination era
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
CETUXIMAB;
FLOXURIDINE;
FLUOROPYRIMIDINE;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
OXALIPLATIN;
ANTINEOPLASTIC AGENT;
ADJUVANT CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL TRIAL;
COLORECTAL CANCER;
HAZARD ASSESSMENT;
HUMAN;
LETTER;
LIVER METASTASIS;
MONOTHERAPY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
RISK FACTOR;
VEIN LIGATION;
COLORECTAL TUMOR;
DISEASE FREE SURVIVAL;
EVIDENCE BASED MEDICINE;
HEPATIC ARTERY;
INTRAARTERIAL DRUG ADMINISTRATION;
LIVER TUMOR;
META ANALYSIS;
METASTASIS;
MORTALITY;
NOTE;
PATHOLOGY;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
DISEASE-FREE SURVIVAL;
EVIDENCE-BASED MEDICINE;
HEPATIC ARTERY;
HUMANS;
INFUSIONS, INTRA-ARTERIAL;
LIVER NEOPLASMS;
META-ANALYSIS AS TOPIC;
TREATMENT OUTCOME;
|
|
EID: 43749121152
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2008.16.5399 Document Type: Letter |
|
Times cited : (5)
|
|
References (4)
|
